Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Gestational Diabetes: full-pipeline trial registry
27 of 42 indexed Gestational Diabetes trials are currently recruiting.
Corpus placement: #347 of 28,707 conditions by registered trial count.
42 US clinical trials · 27 currently recruiting · #347 of 28,707 conditions by registered trial count
Gestational Diabetes: 42 US clinical trials tracked, 27 recruiting.
Gestational Diabetes is the subject of 42 registered US clinical trials on ClinicalTrials.gov, 27 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is Anna Stanhewicz, PhD, running 4 of these trials.
Enrollment posture brief
Registry condition gestational-diabetes
OPEN 27 | RECR 64% | LATE 4 | EARLY 6 | RANK #347 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Cardiac Rehabilitation (64% recruiting · 14 trials)
Gestational Diabetes lists 27 open slots (64% of 42 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Gestational Diabetes on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Gestational Diabetes is recruiting above its size-band peers.
27 of 42 indexed trials (64.3%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Gestational Diabetes trials is spread across many organizations.
Anna Stanhewicz, PhD accounts for 4 of 42 trials (9.5%). 31 distinct sponsors appear on at least one study for this condition label.
-
Typical Gestational Diabetes enrolment sits around 104 participants.
Median target enrolment is 104 among the 42 trials that report a genuine target (sentinel values excluded). 19 of those (45.2%) plan for fewer than 100 participants.
-
Gestational Diabetes research is mostly interventional.
34 interventional and 8 observational studies make up this index (81% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
42 total, page 1 of 1
Delivering HOPE (Helping Women Optimize Prenatal Equity)
University of Arkansas
NCT06814509
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
Indiana University
NCT05124808
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
Tulane University
NCT06116149
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
Thomas Jefferson University
NCT06419803
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes
Thomas Jefferson University
NCT06419777
Gestational Diabetes and Pharmacotherapy (GAP)
Medical College of Wisconsin
NCT03527537
DETERMINE: Detemir vs NPH
University of California, Los Angeles
NCT05124457
Immediate Postpartum Glucose Tolerance Testing
MemorialCare Health System
NCT04199676
Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women
Christiana Care Health Services
NCT06180811
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
The University of Texas Health Science Center, Houston
NCT04206748
Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)
Rutgers, The State University of New Jersey
NCT07171684
GDM: Insulin with or Without Metformin?
University of Virginia
NCT06781775
Preventing T2DM After GDM With Immediate Postpartum Screening
University of Massachusetts, Worcester
NCT06457139
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
Ohio State University
NCT05909046
Preventing Obstetric Complications With Dietary Intervention
Medical College of Wisconsin
NCT06320054
Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)
Montefiore Medical Center
NCT06582719
Glucose Empowerment Through Monitoring and Social Support in Pregnancy
Tufts Medical Center
NCT07009704
Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
University of Tennessee Graduate School of Medicine
NCT06802861
Nutrition Optimization and Community Upliftment for Postpartum Recovery
Johns Hopkins University
NCT06445530
Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM
Anna Stanhewicz, PhD
NCT06547619
Pregnancy and Postpartum CGM in GDM
Icahn School of Medicine at Mount Sinai
NCT07174245
Role of NADPH Oxidase in Microvascular Dysfunction Following GDM
Anna Stanhewicz, PhD
NCT05946798
Growth Hormone Resistance of Beta-cells
University of Missouri-Columbia
NCT06571487
Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes
Anna Stanhewicz, PhD
NCT05917587
Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes
Anna Stanhewicz, PhD
NCT05946785
Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot
Ohio State University
NCT06184373
Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
Maisa N. Feghali, MD
NCT05482789
Glycemic Observation and Metabolic Outcomes in Mothers and Offspring
Northwestern University
NCT04860336
Dilapan-S®: A Multicenter US E-registry
Medicem Technology s.r.o.
NCT04451109
Group Versus Traditional Prenatal Care for Diabetes
Washington University School of Medicine
NCT03301792
Diabetes Prevention Strategies in Women With Gestational Diabetes Mellitus (GDM)
Kaiser Permanente
NCT01344278
Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy
Stanford University
NCT04547023
Oral Glucose Tolerance Testing After Gestational Diabetes
MetroHealth Medical Center
NCT02082301
A Study on the Use of Real -Time Continuous Glucose Monitoring (RT-CGM) in Gestational Diabetes
University of Washington
NCT04803357
Randomized Trial to Evaluate the Effectiveness of Nurse Case Management
Johns Hopkins University
NCT00295256
Diabetes Group Prenatal Care
Washington University School of Medicine
NCT02444325
Soy Supplementation and Gestational Diabetes
University of Massachusetts, Boston
NCT02806739
SWEET: Postpartum Navigation After GDM
Northwestern University
NCT04583839
Magnesium Supplementation in the Second Trimester of Pregnancy to Overweight and Obese Individuals
University of California, Los Angeles
NCT01510665
Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes
Novo Nordisk A/S
NCT00065130
Maternal Health Diabetes Prevention Study
Tulane University
NCT05343494
Postpartum Weight Loss and Exercise (PRIDE)
Pennington Biomedical Research Center
NCT01296516
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Gestational Diabetes records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Gestational Diabetes trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Gestational Diabetes page
42 registered trials, 27 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 27 Gestational Diabetes trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Anna Stanhewicz, PhD sponsors the most Gestational Diabetes trials on record, review their full trial history before evaluating a specific study. See Anna Stanhewicz, PhD's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Gestational Diabetes condition card totals 42 registered trials; most-linked intervention Insulin; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.